WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005111231) COMPOSITIONS, KIT AND ONE-STEP METHOD FOR MONITORING COMPOUNDS HAVING ANTI-FACTOR XA AND/OR ANTI FACTOR IIA ACTIVITIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/111231    International Application No.:    PCT/US2005/016249
Publication Date: 24.11.2005 International Filing Date: 10.05.2005
IPC:
C12Q 1/56 (2006.01)
Applicants: HEPTEST LABORATORIES, INC. [US/US]; 1431 Hanley Industrial Court, St. Louis, MO 63144 (US) (For All Designated States Except US).
YIN, Thye [US/US]; (US) (For US Only)
Inventors: YIN, Thye; (US)
Agent: HART, Daniel; Knobbe, Martens, Olson & Bear, LLP, 2040 Main Street, 14th Floor, Irvine, CA 92614 (US)
Priority Data:
60/570,312 11.05.2004 US
Title (EN) COMPOSITIONS, KIT AND ONE-STEP METHOD FOR MONITORING COMPOUNDS HAVING ANTI-FACTOR XA AND/OR ANTI FACTOR IIA ACTIVITIES
(FR) COMPOSITIONS, KIT ET PROCEDE EN UNE ETAPE PERMETTANT DE SURVEILLER DES COMPOSES POSSEDANT DES ACTIVITES D'ANTIFACTEUR XA ET/OU D'ANTIFACTEUR IIA
Abstract: front page image
(EN)Provided are compositions and methods for accurate determination of the concentration of anticoagulant in a sample such as a blood or plasma sample. The compositions can contain a Factor X compound and Factor V compound, and additional components as well. Methods for performing the assay include one-step methods in which a sample is added to a coagulation assay composition, and time is monitored from the point of adding the sample and coagulation assay composition to an endpoint, such as clot formation.
(FR)La présente invention concerne des compositions et des procédés permettant de déterminer de manière précise la concentration d'un anticoagulant dans un échantillon tel qu'un échantillon de sang ou de plasma. Ces compositions peuvent contenir un composé de facteur X et un composé de facteur V, de même que des composants additionnels. Ces procédés permettent d'effectuer le dosage consistant en des procédés en une étape dans laquelle un échantillon est ajouté à une composition de dosage de coagulation et, on surveille le temps à partir de l'instant d'addition de l'échantillon dans la composition de dosage de coagulation à l'instant final, tel que la formation d'un caillot.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)